HER2-positive tumors are typically highly heterogeneous consisting of differentiated tumor bulk cells and a smaller subset of breast cancer stem cells (BCSCs) with tumorigenic potential and asymmetric cell division capability [15, 16]. Here, ERBB2 is linked to breast carcinoma.